NewsPronto

 
Men's Weekly

.

ACN Newswire

Read more press releases from ACN Newswire here

AbbVie and Eisai Announce an Approval for Partial Changes in the Marketing Approval of HUMIRA, a Fully Human Anti-TNFalpha Monoclonal Antibody

  • Written by ACN Newswire

image

TOKYO, May 29, 2020 - (JCN Newswire) - AbbVie GK and Eisai Co., Ltd. today announced an approval of partial changes in the marketing approval of HUMIRA (generic name: adalimumab [recombinant], hereafter "HUMIRA"), a fully human anti-TNFalpha monoclonal antibody, for additional dosage and administration, specifically, to add an 80mg...

Read more: AbbVie and Eisai Announce an Approval for Partial Changes in the Marketing Approval of HUMIRA, a...